CanniOasis jobs and careers

About CanniOasis

Founded in 2021, CanniOasis has created a theragnostic platform for the development of precision cannabinoid-based drugs that includes state-of-the-art prognostic clinical testing and molecular mapping to guide the personalized treatment of neurological disorders. A key differentiator and competitive advantage for the Company is its midbrain organoid model that will substantially de-risk and shorten the drug development process for neurological disorders.

Founded in 2021 by Kah Meng Lim.